Sedation, orthostasis and priapism are each predicted from a receptor trazodone fills early in this MN660 Unit 3 profile analysis, which treats affinity rankings as forecasts. Searches like "mn 660 unit 3 assignment example", "mn660 unit 3 sample" and "mn660 unit 3 example" land here.
Trazodone's Receptor Profile Read as a Patient Would Feel It
[Student Name]
Purdue University Global
MN660: PMHNP Neuroscience and Psychopharmacology
Unit 3 Assignment
[Instructor Name]
[Date]
A model analysis of one drug's receptor profile. No patient is described; affinity values are bracketed ranges to be filled from the database named.
Methods Note
Affinities are taken as Ki ranges from the NIMH Psychoactive Drug Screening Program database (Roth et al., 2000). A lower Ki means tighter binding. Ki values measured in different assays can differ several-fold, so the analysis compares ranks rather than trusting any single number.
Ranked Table
1. 5-HT2A receptor, antagonist. Ki: [range, low nanomolar]. Occupancy: fills at low exposure.
2. Alpha-1 adrenergic receptor, antagonist. Ki: [range, low nanomolar, overlapping row 1]. Occupancy: fills at low exposure.
3. H1 histamine receptor, antagonist. Ki: [range, higher]. Occupancy: partly filled at low exposure, more at high.
4. 5-HT2C receptor, antagonist. Ki: [range, higher]. Occupancy: mainly at higher exposure.
5. Serotonin transporter, inhibitor. Ki: [range, highest of the five]. Occupancy: meaningful only at high exposure.
The pattern explains the difference between low and high doses. At low exposure, trazodone mainly blocks 5-HT2A, alpha-1 and, to a lesser degree, H1 receptors, which is why small doses are used for sleep. At high exposure it also inhibits the serotonin transporter enough to act as an antidepressant (Stahl, 2009).
Prediction 1: Sedation
Receptors: H1, 5-HT2A and alpha-1. Tissue: brain arousal systems. Blockade: H1 blockade reduces histamine-driven wakefulness; 5-HT2A and alpha-1 blockade add to it. Patient report: drowsiness, the most common complaint and the basis for low-dose use at bedtime. Confidence: high, since all three contribute and the effect appears at low doses.
Prediction 2: Orthostatic Hypotension
Receptor: alpha-1. Tissue: vascular smooth muscle. Blockade: vessels cannot constrict fully on standing. Patient report: lightheadedness on standing, especially in older adults, raising fall risk. Confidence: high.
Prediction 3: Priapism
Receptor: alpha-1. Tissue: erectile smooth muscle. Blockade: impairs the sympathetic signal that ends an erection. Patient report: a prolonged, painful erection, which is rare but a medical emergency. The same receptor that causes lightheadedness in blood vessels causes priapism in erectile tissue, so one row of the table explains two very different effects. Confidence: moderate to high.
Prediction 4: Relatively Few Sexual Side Effects
Receptor: 5-HT2A. Tissue: central pathways involved in sexual function. Blockade: may offset the sexual side effects that follow increased serotonin at 5-HT2A receptors. Patient report: fewer sexual side effects than with SSRIs. Confidence: low to moderate; the 5-HT2A explanation is plausible rather than proven (Stahl, 2009).
The Metabolite mCPP
Trazodone is metabolized by CYP3A4 to m-chlorophenylpiperazine (mCPP), which, unlike the parent drug, stimulates 5-HT2C receptors rather than blocking them. mCPP is cleared by CYP2D6 (Wen et al., 2008). A patient taking a strong CYP2D6 inhibitor could accumulate mCPP, which has been linked to anxiety and other effects, so the metabolite partly works against the parent drug's profile.
What the Profile Does Not Predict
Receptor affinity predicts which effects are possible, not how often they occur in a given person. Age, other medicines, liver function and genetic differences in CYP3A4 and CYP2D6 activity all change exposure, and exposure decides which rows of the table are filled. The profile also says nothing about how quickly tolerance develops to sedation, which many patients report over the first weeks. These limits are why the predictions above are written as likely effects rather than certainties, and why a patient's own report remains the final test of whether a predicted effect has appeared.
References
Roth, B. L., Lopez, E., Patel, S., & Kroeze, W. K. (2000). The multiplicity of serotonin receptors: Uselessly diverse molecules or an embarrassment of riches? The Neuroscientist, 6(4), 252-262. https://doi.org/10.1177/107385840000600408
Stahl, S. M. (2009). Mechanism of action of trazodone: A multifunctional drug. CNS Spectrums, 14(10), 536-546. https://doi.org/10.1017/S1092852900024020
Wen, B., Ma, L., Rodrigues, A. D., & Zhu, M. (2008). Detection of novel reactive metabolites of trazodone: Evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine. Drug Metabolism and Disposition, 36(5), 841-850. https://doi.org/10.1124/dmd.107.019471
How this MN660 Unit 3 example is structured
Placing the table at the top means every later paragraph can cite a specific row above it. A short methods note explains where the affinity values came from and warns that Ki figures from different assays can differ several-fold, so the analysis compares ranks rather than trusting single numbers. Each prediction paragraph then runs in one order: receptor, the tissue where it matters, what blockade does there, what the patient would report, and how confident the link is. Sedation comes first as the most common report, orthostasis second, priapism third as the rarest and most serious. The sexual function paragraph is deliberately hedged, since the 5-HT2A explanation is plausible rather than proven. The mCPP paragraph notes that CYP3A4 forms this metabolite, that it stimulates 5-HT2C rather than blocking it, and that CYP2D6 clears it. The product label and two reviews make up the reference list.
Get an MN660 Unit 3 example written to your instructions
Name the drug whose binding profile the Unit 3 prompt assigns, or let us pick a well-characterized one, and attach the rubric with any required table layout. Written to those instructions, your first analysis comes free within 24-48h: affinities ranked from a cited source, each converted into a predicted effect, and every uncertain link hedged in the text itself. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN660 Unit 3 questions, answered
Where should affinity values come from?
A named database or a peer-reviewed review, cited in the table. The NIMH Psychoactive Drug Screening Program database is widely used and free to search, and product labels sometimes report binding data as well. Whatever the source, compare ranks rather than treating one Ki as exact, and avoid mixing values from different studies in a single column without saying so.
Should the analysis include every receptor the drug touches?
Only those the drug occupies meaningfully at clinical exposure, plus any weak ones that explain something important. For trazodone that means leaving out targets with negligible affinity. A profile padded with receptors that never fill at usual concentrations dilutes the predictions, and graders notice when a row adds nothing to the argument.
Can the analysis compare the drug with another agent?
Briefly, where the comparison sharpens a prediction. Setting trazodone's sexual side effect rate beside an SSRI's, for example, helps explain why 5-HT2A antagonism is proposed as protective. A couple of sentences is plenty unless the prompt requests more, since a full comparison between classes is a separate assignment that usually arrives later in the course.